Advertisement

We should no longer play lip service to lifestyle interventions in the prevention of CVD

      For as long as cardiovascular disease (CVD) prevention has been advocated, and guidance recommendations for clinicians based on the synthesis of existing evidence provided by international guidelines,[
      • Piepoli M.F.
      • Hoes A.W.
      • Agewall S.
      • Albus C.
      • Brotons C.
      • Catapano A.L.
      • Cooney M.T.
      • Corrà U.
      • Cosyns B.
      • Deaton C.
      • Graham I.
      • Hall M.S.
      • Hobbs F.D.R.
      • Løchen M.L.
      • Löllgen H.
      • Marques-Vidal P.
      • Perk J.
      • Prescott E.
      • Redon J.
      • Richter D.J.
      • Sattar N.
      • Smulders Y.
      • Tiberi M.
      • van der Worp H.B.
      • van Dis I.
      • Verschuren W.M.M.
      • Binno S.
      ESC scientific document group. European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European association for cardiovascular prevention & rehabilitation (EACPR).
      ] the benefits of healthy lifestyles have been emphasised. However, compared to the substantial and closely quantifiable benefits of therapeutic interventions, especially supported smoking cessation, blood pressure and lipid lowering medications, recommendations around lifestyle changes have been largely generic comments and essentially statements of ‘common-sense’.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Piepoli M.F.
        • Hoes A.W.
        • Agewall S.
        • Albus C.
        • Brotons C.
        • Catapano A.L.
        • Cooney M.T.
        • Corrà U.
        • Cosyns B.
        • Deaton C.
        • Graham I.
        • Hall M.S.
        • Hobbs F.D.R.
        • Løchen M.L.
        • Löllgen H.
        • Marques-Vidal P.
        • Perk J.
        • Prescott E.
        • Redon J.
        • Richter D.J.
        • Sattar N.
        • Smulders Y.
        • Tiberi M.
        • van der Worp H.B.
        • van Dis I.
        • Verschuren W.M.M.
        • Binno S.
        ESC scientific document group. European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European association for cardiovascular prevention & rehabilitation (EACPR).
        Eur Heart J. 2016; 2016: 2315
        • Cimminiello C.
        Never enough recommended. Beyond the AHA/ACC guideline on lifestyle and behavior for cardiovascular prevention.
        Eur J Inter Med. 2020; 70: 8-9
        • Estruch R.
        • et al.
        Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts.
        N. Engl. J. Med. 2018; 378
        • Naci H.
        • Salcher-Konrad M.
        • Dias S.
        • Blum M.R.
        • Sahoo S.A.
        • Nunan D.
        • Ioannidis J.P.A.
        How does exercise treatment compare with antihypertensive medications? A net-work meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure.
        Br J Sports Med. 2019; 53: 859-869
        • Jeong S.-W.
        • Kim S.-H.
        • Kang S.-H.
        • Kim H.-J.
        • Yoon C.-H.
        • Youn T.-J.
        • Chae I.-H.
        Mortality reduction with physical activity in patients with and without cardiovascular disease.
        Eur Heart J. 2019; 40: 3547-3555
        • Kotseva K.
        • De Backer G.
        • De Bacquer D.
        • Rydén L.
        • Hoes A.
        • Grobbee D.
        • Maggioni A.
        • Marques-Vidal P.
        • Jennings C.
        • Abreu A.
        • Aguiar C.
        • Badariene J.
        • Bruthans J.
        • Castro Conde A.
        • Cifkova R.
        • Crowley J.
        • Davletov K.
        • Deckers J.
        • De Smedt D.
        • De Sutter J.
        • Dilic M.
        • Dolzhenko M.
        • Dzerve V.
        • Erglis A.
        • Fras Z.
        • Gaita D.
        • Gotcheva N.
        • Heuschmann P.
        • Hasan-Ali H.
        • Jankowski P.
        • Lalic N.
        • Lehto S.
        • Lovic D.
        • Mancas S.
        • Mellbin L.
        • Milicic D.
        • Mirrakhimov E.
        • Oganov R.
        • Pogosova N.
        • Reiner Z.
        • Stöerk S.
        • Tokgözoğlu L.
        • Tsioufis C.
        • Vulic D.
        • Wood D.
        EUROASPIRE investigators. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European society of cardiology esc-eorp euroaspire V registry.
        Eur J Prev Cardiol. 2019; 26: 824-835